Trial Profile
Multicentre Study For Evaluation Of The Efficacy And Safety Of Buprenorphine Transdermal Patch (SOVENOR Transdermal Patch 5mg And 10mg) In Patients With Non-malignant Pain Of Moderate Intensity Due To Osteoarthritis, Rheumatoid Arthritis, Lower Back Pain And Joint /Muscle Pain, When An Opioid Is Necessary For Obtaining Adequate Analgesia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Jul 2016
Price :
$35
*
At a glance
- Drugs Buprenorphine (Primary)
- Indications Back pain; Musculoskeletal pain; Pain
- Focus Therapeutic Use
- Sponsors Mundipharma Pharmaceuticals Sdn Bhd
- 13 Aug 2015 New trial record